Literature DB >> 15288613

Molecular epidemiology of hepatitis B virus infections in Denmark.

Niels Fisker1, Court Pedersen, Marianne Lange, Nga Thien Tich Nguyen, Kim Thien Tich Nguyen, Jørgen Georgsen, Peer Brehm Christensen.   

Abstract

BACKGROUND: Denmark has a low incidence of acute hepatitis B (HBV) infections but the impact of an increasing number of immigrants with chronic HBV infection on HBV transmission is unknown.
OBJECTIVES: To characterise individuals with chronic and acute HBV infection in a defined region and to examine the importance of different risk groups for the current HBV transmission.
METHODS: During 2000-2001 all consecutive HBV infected individuals routinely diagnosed through the regional HBV serology laboratory in the County of Funen were classified according to ethnicity, presumed route of transmission and stage of infection based on clinical data mainly supplied by the requesting physician. HBV DNA was sequenced and subjected to phylogenetic analysis.
RESULTS: Of 309 identified cases, 91 (29%) were classified as acute infection. HBV DNA sequencing was possible in 54 (59%) of these cases. Phylogenetic analysis showed that HBV isolated from injecting drug users (IDUs) was identical or closely related. Among acute cases acquired in Denmark 89% (74/83) were seen in IDUs (65) or in individuals presumably exposed to IDUs (nine) and phylogenetic analysis corroborated the assumption of IDU related transmission in every case with available sequence data. Among 83 ethnic Danes who acquired their HBV infection in Denmark, no new cases of transmission from immigrants were detected.
CONCLUSION: Injecting drug use was the single most important factor for hepatitis B transmission in Denmark. The current Danish vaccination strategy is unable to protect IDUs from HBV infection and IDUs pose a greater risk of HBV transmission to the general population than immigrants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288613     DOI: 10.1016/j.jcv.2004.05.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Identifying a hepatitis B outbreak by molecular surveillance: a case study.

Authors:  N Fisker; N L T Carlsen; H J Kolmos; L Tønning-Sørensen; A Høst; P B Christensen
Journal:  BMJ       Date:  2006-02-11

2.  Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009.

Authors:  Gražina Rimšelienė; Øivind Nilsen; Hilde Kløvstad; Hans Blystad; Preben Aavitsland
Journal:  BMC Infect Dis       Date:  2011-05-26       Impact factor: 3.090

3.  HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Authors:  R Ranjbar; A Davari; M Izadi; N Jonaidi; S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

4.  Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada.

Authors:  Carla Osiowy; Elizabeth Giles; Max Trubnikov; Yogesh Choudhri; Anton Andonov
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

5.  Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China.

Authors:  H W Zhang; J H Yin; Y T Li; C Z Li; H Ren; C Y Gu; H Y Wu; X S Liang; P Zhang; J F Zhao; X J Tan; W Lu; S Schaefer; G W Cao
Journal:  Gut       Date:  2008-08-28       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.